SCHEMBL4686907

SCHEMBL4686907

COc1cc2ncnc(NC(=S)Nc3c(C)cccc3C)c2cc1OC1CCOCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 10/20 0.57
SOS1 Q07889 1/20 0.57
ERBB2 P04626 4/20 0.49
KDR P35968 4/20 0.49
EPHA2 P29317 2/20 0.49
EPHB4 P54760 2/20 0.49
PDE10A Q9Y233 1/20 0.44
RET P07949 2/20 0.44
KIF5B P33176 2/20 0.44
FGFR1 P11362 1/20 0.44
FLT1 P17948 1/20 0.44
CDK2 P24941 1/20 0.44
PIK3R1 P27986 1/20 0.44
EPHB2 P29323 1/20 0.44
TTBK1 Q5TCY1 1/20 0.44
NOD1 Q9Y239 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
SRC P12931 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4690213 0.95 KDR (0.55) EGFRSOS1ERBB2KDREPHA2
SCHEMBL4690909 0.84 EGFR (0.46) EGFRERBB2KDREPHA2EPHB4
SCHEMBL4689353 0.83 KDR (0.55) EGFRERBB2KDREPHA2EPHB4
SCHEMBL4693053 0.82 RET (0.62) ERBB2KDREPHA2EPHB4RET
SCHEMBL4693034 0.81 RET (0.59) ERBB2KDREPHA2EPHB4RET
SCHEMBL4693023 0.81 RET (0.61) EGFRKDREPHA2EPHB4RET
SCHEMBL4690799 0.80 SRC (0.64) EGFRKDRRETKIF5BALDH1A1
SCHEMBL4689817 0.80 SRC (0.64) EGFRKDRRETKIF5BALDH1A1
SCHEMBL5828725 0.79 FLT1 (0.62) EGFRERBB2KDREPHB4RET
SCHEMBL5832489 0.79 FLT1 (0.62) EGFRERBB2KDREPHB4RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed